Hormones and Sarcopenia
The DOI matches its Crossref record.
Abstract
Sarcopenia is defined as the loss of muscle mass associated with a loss of muscle function, e.g., walking speed. A number of consensus definitions exist for sarcopenia with cut-off points being ethnically specific. A rapid screen test (SARC-F) is available and does not require different ethnic cut-off points. Sarcopenia leads to the development of frailty, disability and mortality. The prevalence of sarcopenia varies from 1-29% in community- dwelling and 14 to 33% in long-term care populations. Hormones play a role in the development of muscle mass and in the regulation of muscle strength. Testosterone appears to be the central hormone involved in the development of sarcopenia; it increases both muscle mass and activates satellite cells leading to increased muscle function. Growth hormone deficiency leads to the loss of muscle mass but not muscle strength. Lack of insulin or insulin resistance leads to accelerated development of sarcopenia. Vitamin D deficiency plays a role in the loss of muscle strength. A variety of other hormones appear to play minor roles in age-related alterations in muscle mass and function. At present, the treatment of sarcopenia is resistance exercise, leucine enriched essential amino acids or hydroxymethylbutyrate and vitamin D replacement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update
Jimenez-Gutierrez, G. E., Martínez-Gómez, L. E., Martínez-Armenta, C., Pineda, C., Martínez-Nava, G. A., & Lopez-Reyes, A. (2022) · Cells · doi:10.3390/cells11152359 · Cited by 231
“Testosterone [76,77] Interacts with androgen receptor (AR), leading to its nuclear translocation to regulate myogenic expression Increase in muscle mass and strength”
BackgroundKadambi, S., Loh, K. P., Dunne, R., Magnuson, A., Maggiore, R., Zittel, J., Flannery, M., Inglis, J., Gilmore, N., Mohamed, M., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0421-z · Cited by 149
Thyroid Function and Sarcopenia: Results from the ELSA-Brasil Study
Szlejf, C., Suemoto, C. K., Janovsky, C. C. P. S., Barreto, S. M., Diniz, M. D. F. H. S., Lotufo, P. A., & Bensenor, I. M. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16416 · Cited by 60
Gao, X., Chen, Y., & Cheng, P. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1338875 · Cited by 41
Jung, W.-S., Kim, Y.-Y., Kim, J.-W., & Park, H.-Y. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304134 · Cited by 30
“In addition, fat infiltration in the skeletal muscle worsens insulin resistance [5], and the vicious cycle of reduction in energy consumption and increased risk of falling is as a result of greater sarcopenia and obesity [6].”
Background
Metadata
- Authors
- Morley, J. E.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2017-11-28
- Volume
- 23
- Issue
- 30
- Pages
- 4484-4492
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2613688787
- Cited by
- 99
- References
- 0
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hormones and Sarcopenia. https://app.cochat.ai/papers/10.2174/1381612823666161123150032
- The paper
- Morley, J. E. (2017). Hormones and Sarcopenia. Current Pharmaceutical Design. https://doi.org/10.2174/1381612823666161123150032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.